Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer

por Araki, K, Yamashita, T, Reddy, N, Wang, H, Abuzeid, W M, Khan, K, O'Malley, B W, Li, D
Publicado 2010

Biliverdin's regulation of reactive oxygen species signalling leads to potent inhibition of proliferative and angiogenic pathways in head and neck cancer

por Zheng, J, Nagda, D A, Lajud, S A, Kumar, S, Mouchli, A, Bezpalko, O, O'Malley, B W, Li, D
Publicado 2014